The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
High-Density Lipoprotein Cholesterol and Particle Concentrations, Carotid Atherosclerosis, and Coronary Events
Open accessAbstract
Objectives To evaluate independent associations of high density lipoprotein cholesterol (HDL-C) and particle (HDL-P) concentrations with carotid intima-media thickness (cIMT) and incident coronary heart disease (CHD). Background HDL-C is inversely related to CHD, but also to triglycerides, LDL particles (LDL-P), and related metabolic risk. HDL-P associations with CHD may be partially independent of these factors. Methods In a multi-ethnic study of 5598 men and women ages 45-84, without baseline CHD, excluding subjects on lipid-lowering medications, triglycerides >400 mg/dl or missing values, we evaluated associations of HDL-C and NMR-spectroscopy-measured HDL-P with cIMT and incident CHD (myocardial infarction, CHD death, angina, n=227 events, 6.0 years mean follow-up). All models were adjusted for age, sex, ethnicity, hypertension and smoking. Results HDL-C and HDL-P correlated with each other (π=0.69) and LDL-P (π = −0.38, −0.25, respectively), p<0.05 for all. For (1-SD) higher HDL-C (15 mg/dl) or HDL-P (6.64 μmol/l), cIMT differences (95%CI) were −26.1(−34.7,−17.4) and −30.1 (−38.8,−21.4) μm, and CHD hazard ratios (HR (95%CI)) were 0.74 (0.63, 0.88) and 0.70 (0.59, 0.82), respectively. Adjusted for each other and LDL-P, HDL-C was no longer associated with cIMT (2.3 (−9.5, 14.2) μm) or CHD (0.97(0.77, 1.22)), but HDL-P remained independently associated with cIMT (−22.2(−33.8,−10.6) μm) and CHD (0.75 (0.61, 0.93)). Interactions by sex, ethnicity, diabetes and high-sensitivity C-reactive protein were not significant. Conclusions Adjusting for each other and LDL-P substantially attenuated associations of HDL-C, but not HDL-P, with cIMT and CHD. Potential confounding by related lipids or lipoproteins should be carefully considered when evaluating HDL-related risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
O'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
Bild, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf113 · Cited by 3,942
Effects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837 · cited 1×
“ing cardiovascular disease (CVD) events (5,6) or atherosclerosis (7) have also fueled interest in alternative indexes of HDL quantity (i.”
BackgroundCholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943
Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
Nissen, S. E., Tardif, J.-C., Nicholls, S. J., Revkin, J. H., Shear, C. L., Duggan, W. T., Ruzyllo, W., Bachinsky, W. B., Lasala, G. P., & Tuzcu, E. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070635 · Cited by 966
The Relationship of Left Ventricular Mass and Geometry to Incident Cardiovascular Events
Bluemke, D. A., Kronmal, R. A., Lima, J. A. C., Liu, K., Olson, J., Burke, G. L., & Folsom, A. R. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.014 · Cited by 808
Lipoprotein Particle Analysis by Nuclear Magnetic Resonance Spectroscopy
Jeyarajah, E. J., Cromwell, W. C., & Otvos, J. D. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.07.006 · Cited by 732
Otvos, J. D., Collins, D., Freedman, D. S., Shalaurova, I., Schaefer, E. J., McNamara, J. R., Bloomfield, H. E., & Robins, S. J. (2006) · Circulation · doi:10.1161/circulationaha.105.565135 · Cited by 547
Rosenson, R. S., Brewer, H. B., Chapman, M. J., Fazio, S., Hussain, M. M., Kontush, A., Krauss, R. M., Otvos, J. D., Remaley, A. T., & Schaefer, E. J. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.155333 · Cited by 511
Mora, S., Otvos, J. D., Rifai, N., Rosenson, R. S., Buring, J. E., & Ridker, P. M. (2009) · Circulation · doi:10.1161/circulationaha.108.816181 · Cited by 490
Self-citationHigh-Density Lipoprotein as a Therapeutic Target: A Systematic Review
Singh, I. M., Shishehbor, M. H., & Ansell, B. J. (2007) · JAMA · doi:10.1001/jama.298.7.786 · Cited by 468
Clinical implications of discordance between low-density lipoprotein cholesterol and particle number
Otvos, J. D., Mora, S., Shalaurova, I., Greenland, P., Mackey, R. H., & Goff, D. C. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.02.001 · Cited by 384
Self-citationMora, S., Szklo, M., Otvos, J. D., Greenland, P., Psaty, B. M., Goff, D. C., O’Leary, D. H., Saad, M. F., Tsai, M. Y., & Sharrett, A. R. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.007 · Cited by 380
Self-citationvan der Steeg, W. A., Holme, I., Boekholdt, S. M., Larsen, M. L., Lindahl, C., Stroes, E. S. G., Tikkanen, M. J., Wareham, N. J., Faergeman, O., Olsson, A. G., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.060 · Cited by 374
Beyond High-Density Lipoprotein Cholesterol Levels
deGoma, E. M., deGoma, R. L., & Rader, D. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.016 · Cited by 253
Gepner, A. D., Piper, M. E., Johnson, H. M., Fiore, M. C., Baker, T. B., & Stein, J. H. (2011) · American Heart Journal · doi:10.1016/j.ahj.2010.09.023 · Cited by 242
High-Density Lipoprotein Particle Size and Concentration and Coronary Risk
El Harchaoui, K., Arsenault, B. J., Franssen, R., Després, J.-P., Hovingh, G. K., Stroes, E. S. G., Otvos, J. D., Wareham, N. J., Kastelein, J. J. P., Khaw, K.-T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-2-200901200-00006 · Cited by 227
The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?
Vergeer, M., Holleboom, A. G., Kastelein, J. J. P., & Kuivenhoven, J. A. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r001610 · Cited by 220
Smoking intensity and lipoprotein abnormalities in active smokers
Gossett, L. K., Johnson, H. M., Piper, M. E., Fiore, M. C., Baker, T. B., & Stein, J. H. (2009) · Journal of clinical lipidology · doi:10.1016/j.jacl.2009.10.008 · Cited by 122
Why is HDL functionally deficient in type 2 diabetes?
Kontush, A., & Chapman, M. J. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0010-5 · Cited by 116
Lipoprotein particle subclasses, cardiovascular disease and HIV infection
Duprez, D. A., Kuller, L. H., Tracy, R. P., Otvos, J. D., Cooper, D. A., Hoy, J., Neuhaus, J., Paton, N. I., Friis‐Møller, N., Lampe, F. C., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.001 · Cited by 111
Johannsen, T. H., Kamstrup, P. R., Andersen, R. V., Jensen, G. B., Sillesen, H. H., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1342 · Cited by 99
Frikke-Schmidt, R. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.06.005 · Cited by 94
Alcohol Consumption and Lipoprotein Subclasses in Older Adults
Mukamal, K. J., Mackey, R. H., Kuller, L. H., Tracy, R. P., Kronmal, R. A., Mittleman, M. A., & Siscovick, D. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2422 · Cited by 78
Self-citationKuller, L. H., Grandits, G. A., Cohen, J. D., Neaton, J. D., & Prineas, R. J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.09.001 · Cited by 72
Inflammation reduces HDL protection against primary cardiac risk
Corsetti, J. P., Gansevoort, R. T., Sparks, C. E., & Dullaart, R. P. F. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02287.x · Cited by 68
Can dysfunctional HDL explain high coronary artery disease risk in South Asians?
Dodani, S., Kaur, R., Reddy, S. N., Reed, G. L., Navab, M., & George, V. T. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.12.019 · Cited by 66
Rosenson, R. S., Otvos, J. D., & Hsia, J. A. (2009) · Diabetes Care · doi:10.2337/dc08-1681 · Cited by 65
The Women on the Move Through Activity and Nutrition (WOMAN) Study: Final 48‐Month Results
Kuller, L. H., Gabriel, K. P., Kinzel, L. S., Underwood, D. A., Conroy, M. B., Chang, Y., Mackey, R. H., Edmundowicz, D., Tyrrell, K. S., Buhari, A. M., et al. (2011) · Obesity · doi:10.1038/oby.2011.80 · Cited by 59
Self-citationFan, A. Z., & Dwyer, J. H. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.045 · Cited by 55
Hsia, J. A., Otvos, J. D., Rossouw, J. E., Wu, L., Wassertheil-Smoller, S. W., Hendrix, S. L., Robinson, J. G., Lund, B., & Kuller, L. H. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.170431 · Cited by 55
Farbstein, D., Blum, S., Pollak, M., Asaf, R., Viener, H. L., Lache, O., Asleh, R., Miller‐Lotan, R., Barkay, I., Star, M., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.005 · Cited by 38
Tan, H. C., Tai, E. S., Sviridov, D., Nestel, P. J., Ng, C. L. W., Chan, E., Teo, Y., & Wai, D. C. H. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.06.016 · Cited by 37
Jafri, H., Alsheikh-Ali, A. A. A., Mooney, P., Kimmelstiel, C. D., Karas, R. H., & Kuvin, J. T. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.12.003 · Cited by 29
Rashedi, N., Brennan, D. M., Kastelein, J. J. P., Nissen, S. E., & Nicholls, S. (2011) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(11)70218-5 · Cited by 12
The relationship between physical activity and lipoprotein subclasses in postmenopausal women
Gabriel, K. P., Kriska, A. M., Johnson, B. D., Conroy, M. B., Mackey, R. H., Orchard, T. J., & Kuller, L. H. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000229573.29258.d5 · Cited by 11
Self-citation
Cited by
Soininen, P., Kangas, A. J., Würtz, P., Suna, T., & Ala-Korpela, M. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.114.000216 · Cited by 900
HDL and cardiovascular disease
Rader, D. J., & Hovingh, G. K. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61217-4 · Cited by 870
High-density lipoprotein revisited: biological functions and clinical relevance
von Eckardstein, A., Nordestgaard, B. G., Remaley, A. T., & Catapano, A. L. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehac605 · Cited by 401
Sleep Irregularity and Risk of Cardiovascular Events
Huang, T., Mariani, S., & Redline, S. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.054 · Cited by 363
HDL-targeted therapies: progress, failures and future
Kingwell, B. A., Chapman, M. J., Kontush, A., & Miller, N. E. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4279 · Cited by 354
Metadata
- Authors
- Mackey, R. H., Greenland, P., Goff, D. C., Lloyd-Jones, D., Sibley, C. T., & Mora, S.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 60
- Issue
- 6
- Pages
- 508-516
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W1515206644
- Cited by
- 363
- References
- 39
- FWCI
- 40.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.